Arkolith/Insider Trading/IMPL/Form 4

venBio Global Strategic Fund II L.P.

10% OwnerIMPEL NEUROPHARMA INC (IMPL) · full profile →Form 4 · filed Apr 29, 2021
Net Buying
Open-Market Buys
$6.8M
Open-Market Sells
$0
Net Open-Market Flow
$6.8M
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2021Buy(P)450K$15.00$6.8M2.8M
Apr 27, 2021Conversion(C)2.3M——2.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2021Conversion(C)5.9M—$00
Apr 27, 2021Conversion(C)0—$00
Apr 27, 2021Conversion(C)13.2M—$00
Apr 27, 2021Conversion(C)8.2M—$00
Apr 27, 2021Conversion(C)8.8M—$00

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-21-000408) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML